These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 12529157)
1. Exploring the interaction energies for the binding of hydroxydiphenyl ethers to enoyl-acyl carrier protein reductases. Muralidharan J; Suguna K; Surolia A; Surolia N J Biomol Struct Dyn; 2003 Feb; 20(4):589-94. PubMed ID: 12529157 [TBL] [Abstract][Full Text] [Related]
2. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. Kapoor M; Dar MJ; Surolia A; Surolia N Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121 [TBL] [Abstract][Full Text] [Related]
3. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum. Suguna K; Surolia A; Surolia N Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792 [TBL] [Abstract][Full Text] [Related]
4. A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase. Levy CW; Baldock C; Wallace AJ; Sedelnikova S; Viner RC; Clough JM; Stuitje AR; Slabas AR; Rice DW; Rafferty JB J Mol Biol; 2001 May; 309(1):171-80. PubMed ID: 11491286 [TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum. Kapoor M; Gopalakrishnapai J; Surolia N; Surolia A Biochem J; 2004 Aug; 381(Pt 3):735-41. PubMed ID: 15139852 [TBL] [Abstract][Full Text] [Related]
7. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene. Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521 [TBL] [Abstract][Full Text] [Related]
8. Novel diphenyl ethers: design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli. Chhibber M; Kumar G; Parasuraman P; Ramya TN; Surolia N; Surolia A Bioorg Med Chem; 2006 Dec; 14(23):8086-98. PubMed ID: 16893651 [TBL] [Abstract][Full Text] [Related]
9. Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy. Surolia N; RamachandraRao SP; Surolia A Bioessays; 2002 Feb; 24(2):192-6. PubMed ID: 11835284 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. Heath RJ; Li J; Roland GE; Rock CO J Biol Chem; 2000 Feb; 275(7):4654-9. PubMed ID: 10671494 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the Helicobacter pylori enoyl-acyl carrier protein reductase in complex with hydroxydiphenyl ether compounds, triclosan and diclosan. Lee HH; Moon J; Suh SW Proteins; 2007 Nov; 69(3):691-4. PubMed ID: 17879346 [No Abstract] [Full Text] [Related]
12. Structural basis for the variation in triclosan affinity to enoyl reductases. Pidugu LS; Kapoor M; Surolia N; Surolia A; Suguna K J Mol Biol; 2004 Oct; 343(1):147-55. PubMed ID: 15381426 [TBL] [Abstract][Full Text] [Related]
13. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase. Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979 [TBL] [Abstract][Full Text] [Related]
14. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Surolia N; Surolia A Nat Med; 2001 Feb; 7(2):167-73. PubMed ID: 11175846 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs. Sivaraman S; Zwahlen J; Bell AF; Hedstrom L; Tonge PJ Biochemistry; 2003 Apr; 42(15):4406-13. PubMed ID: 12693936 [TBL] [Abstract][Full Text] [Related]
16. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA. Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698 [TBL] [Abstract][Full Text] [Related]
17. Role of inhibitor aliphatic chain in the thermodynamics of inhibitor binding to Escherichia coli enoyl-ACP reductase and the Phe203Leu mutant: a proposed mechanism for drug resistance. Protasevich II; Brouillette CG; Snow ME; Dunham S; Rubin JR; Gogliotti R; Siegel K Biochemistry; 2004 Oct; 43(42):13380-9. PubMed ID: 15491144 [TBL] [Abstract][Full Text] [Related]
18. X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition. Maity K; Bhargav SP; Sankaran B; Surolia N; Surolia A; Suguna K IUBMB Life; 2010 Jun; 62(6):467-76. PubMed ID: 20503440 [TBL] [Abstract][Full Text] [Related]
19. Kinetic and structural analysis of the increased affinity of enoyl-ACP (acyl-carrier protein) reductase for triclosan in the presence of NAD+. Kapoor M; Mukhi PL; Surolia N; Suguna K; Surolia A Biochem J; 2004 Aug; 381(Pt 3):725-33. PubMed ID: 15125687 [TBL] [Abstract][Full Text] [Related]
20. Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from Plasmodium falciparum. Maity K; Banerjee T; Prabakaran N; Surolia N; Surolia A; Suguna K IUBMB Life; 2011 Jan; 63(1):30-41. PubMed ID: 21280175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]